EGFR and acute myeloid leukemia: Four of the ten highest ranked pathways are receptor-mediated signaling pathways (erbB, neurotrophin, TGF-β, and T cell receptor) and of these, it was decided to focus on the TGF-β family pathway firstly because of its known relevance to hematopoiesis, where it tends to inhibit proliferation while stimulating differentiation and apoptosis [32], and secondly because the pharmacologic neutralization of TGF-β1 has been previously observed to enhance ARA-C-induced apoptosis in AML cells [33].